{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:43:29Z","timestamp":1740123809915,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10633-023-09920-3","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T06:03:13Z","timestamp":1674021793000},"page":"121-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of visual electrodiagnostics in management of children with neurofibromatosis type 1"],"prefix":"10.1007","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3730-0229","authenticated-orcid":false,"given":"Manca","family":"Tekav\u010di\u010d Pompe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3939-613X","authenticated-orcid":false,"given":"Nu\u0161ka","family":"Pe\u010dari\u010d Megli\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6321-6931","authenticated-orcid":false,"given":"Maja","family":"\u0160u\u0161tar Habjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"9920_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00439-002-0871-7","volume":"112","author":"J Szudek","year":"2003","unstructured":"Szudek J, Evans DG, Friedman JM (2003) Patterns of associations of clinical features in neurofibromatosis 1 (NF1). Hum Genet 112:289\u2013297. https:\/\/doi.org\/10.1007\/s00439-002-0871-7. (Epub 2002 Dec 20)","journal-title":"Hum Genet"},{"key":"9920_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143\u2013149. https:\/\/doi.org\/10.1002\/ana.410410204","journal-title":"Ann Neurol"},{"key":"9920_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s0002-9394(00)00852-7","volume":"131","author":"LJ Balcer","year":"2001","unstructured":"Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131:442\u2013445. https:\/\/doi.org\/10.1016\/s0002-9394(00)00852-7","journal-title":"Am J Ophthalmol"},{"key":"9920_CR4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC), Huson SM, Evans DG, Plotkin SR (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"9920_CR5","first-page":"700","volume-title":"Taylor and Hoyt\u2019s pediatric ophthalmology and strabismus","author":"JRB Grigg","year":"2016","unstructured":"Grigg JRB, Jamieson RV (2016) Phakomatoses (including the neurofibromatoses). In: Lambert S, Lyons C (eds) Taylor and Hoyt\u2019s pediatric ophthalmology and strabismus, 5th edn. Elsevier, pp 700\u2013714","edition":"5"},{"issue":"3","key":"9920_CR6","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"23","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Prim 23(3):17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4. (PMID: 28230061)","journal-title":"Nat Rev Dis Prim"},{"key":"9920_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3325\/cmj.2011.52.488","volume":"52","author":"Z Sabol","year":"2011","unstructured":"Sabol Z, Resi\u0107 B, GjergjaJuraski R, Sabol F, KovacSizgori\u0107 M, Orsoli\u0107 K, Ozreti\u0107 D, Sepi\u0107-Grahovac D (2011) Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study. Croat Med J 52:488\u2013496. https:\/\/doi.org\/10.3325\/cmj.2011.52.488","journal-title":"Croat Med J"},{"key":"9920_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13:834\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"key":"9920_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0883073817739509","volume":"33","author":"CJ Campen","year":"2018","unstructured":"Campen CJ, Gutmann DH (2018) Optic pathway gliomas in neurofibromatosis type 1. J Child Neurol 33:73\u201381. https:\/\/doi.org\/10.1177\/0883073817739509","journal-title":"J Child Neurol"},{"key":"9920_CR10","unstructured":"Paediatric imaging under general anaesthetic. Royal College of Anaesthetists guidance. November 2021. Available at: https:\/\/www.rcoa.ac.uk\/sites\/default\/files\/documents\/2022 Accessed 17 July 2022"},{"key":"9920_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jaapos.2006.02.004","volume":"10","author":"DH Wolsey","year":"2006","unstructured":"Wolsey DH, Larson SA, Creel D, Hoffman R (2006) Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 10:307\u2013311. https:\/\/doi.org\/10.1016\/j.jaapos.2006.02.004","journal-title":"J AAPOS"},{"key":"9920_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/a:1015719803719","volume":"105","author":"A Iannaccone","year":"2002","unstructured":"Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC, Pivnick EK (2002) Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 105:63\u201381. https:\/\/doi.org\/10.1023\/a:1015719803719","journal-title":"Doc Ophthalmol"},{"key":"9920_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s1388-2457(03)00282-7","volume":"115","author":"MT Trisciuzzi","year":"2004","unstructured":"Trisciuzzi MT, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, Colosimo C Jr, Ruggiero A, Di Rocco C, Falsini B (2004) A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 115:217\u2013226. https:\/\/doi.org\/10.1016\/s1388-2457(03)00282-7","journal-title":"Clin Neurophysiol"},{"key":"9920_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1120672120906989","volume":"31","author":"A Vagge","year":"2021","unstructured":"Vagge A, Camicione P, Pellegrini M, Gatti G, Capris P, Severino M, Di Maita M, Panarello S, Traverso CE (2021) Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I. Eur J Ophthalmol 31:698\u2013703. https:\/\/doi.org\/10.1177\/1120672120906989","journal-title":"Eur J Ophthalmol"},{"key":"9920_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02096-1","author":"R Bowman","year":"2022","unstructured":"Bowman R, Walters B, Smith V, Prise KL, Handley SE, Green K, Mankad K, O\u2019Hare P, Dahl C, Jorgensen M, Opocher E, Hargrave D, Thompson DA (2022) Visual outcomes and predictors in optic pathway glioma: a single centre study. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-022-02096-1","journal-title":"Eye (Lond)"},{"key":"9920_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","volume":"126","author":"M Bach","year":"2013","unstructured":"Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, Meigen T, Viswanathan S (2013) ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol 126:1\u20137. https:\/\/doi.org\/10.1007\/s10633-012-9353-y","journal-title":"Doc Ophthalmol"},{"key":"9920_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","volume":"133","author":"JV Odom","year":"2016","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP, International Society for Clinical Electrophysiology of Vision (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133:1\u20139. https:\/\/doi.org\/10.1007\/s10633-016-9553-y","journal-title":"Doc Ophthalmol"},{"key":"9920_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/aos.14938","volume":"100","author":"OR Marmoy","year":"2021","unstructured":"Marmoy OR, Moinuddin M, Thompson DA (2021) An alternative electroretinography protocol for children: a study of diagnostic agreement and accuracy relative to ISCEV standard electroretinograms. Acta Ophthalmol 100:322\u2013330. https:\/\/doi.org\/10.1111\/aos.14938","journal-title":"Acta Ophthalmol"},{"key":"9920_CR19","first-page":"68","volume-title":"Taylor and Hoyt\u2019s pediatric ophthalmology and strabismus","author":"DA Thompson","year":"2016","unstructured":"Thompson DA, Liasis A (2016) Visual electrophysiology: how it can help you and your patient. In: Lambert S, Lyons C (eds) Taylor and Hoyt\u2019s pediatric ophthalmology and strabismus, 5th edn. Elsevier, pp 68\u201375","edition":"5"},{"key":"9920_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0022-3476(94)70122-9","volume":"125","author":"R Listernick","year":"1994","unstructured":"Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63\u201366. https:\/\/doi.org\/10.1016\/s0022-3476(94)70122-9","journal-title":"J Pediatr"},{"key":"9920_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","volume":"111","author":"S Thiagalingam","year":"2004","unstructured":"Thiagalingam S, Flaherty M, Billson F, North K (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568\u2013577","journal-title":"Ophthalmology"},{"key":"9920_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis 1: controversies and recommendations. Ann Neurol 61:189\u2013198. https:\/\/doi.org\/10.1002\/ana.21107","journal-title":"Ann Neurol"},{"key":"9920_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1167\/iovs.11-8225","volume":"53","author":"MJ Ribeiro","year":"2012","unstructured":"Ribeiro MJ, Violante IR, Bernardino I, Ramos F, Saraiva J, Reviriego P, Upadhyaya M, Silva ED, Castelo-Branco M (2012) Abnormal achromatic and chromatic contrast sensitivity in neurofibromatosis type 1. Invest Ophthalmol Vis Sci 53:287\u2013293. https:\/\/doi.org\/10.1167\/iovs.11-8225","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9920_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/eye.1993.20","volume":"7","author":"NK Ragge","year":"1993","unstructured":"Ragge NK, Falk RE, Cohen WE, Murphree AL (1993) Images of Lisch nodules across the spectrum. Eye (Lond) 7:95\u2013101. https:\/\/doi.org\/10.1038\/eye.1993.20","journal-title":"Eye (Lond)"},{"key":"9920_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2020.03.053","volume":"221","author":"M Kinori","year":"2021","unstructured":"Kinori M, Armarnik S, Listernick R, Charrow J, Zeid JL (2021) Neurofibromatosis type 1-associated optic pathway glioma in children: a follow-up of 10 years or more. Am J Ophthalmol 221:91\u201396. https:\/\/doi.org\/10.1016\/j.ajo.2020.03.053","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"9920_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0887-8994(94)90043-4","volume":"10","author":"K North","year":"1994","unstructured":"North K, Cochineas C, Tang E, Fagan E (1994) Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 10(2):117\u2013123. https:\/\/doi.org\/10.1016\/0887-8994(94)90043-4. (PMID: 8024659)","journal-title":"Pediatr Neurol"},{"key":"9920_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","volume":"68","author":"B Hegedus","year":"2009","unstructured":"Hegedus B, Hughes FW, Garbow JR, Gianino S, Banerjee D, Kim K, Ellisman MH, Brantley MA Jr, Gutmann DH (2009) Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma. J Neuropathol Exp Neurol 68:542\u2013551. https:\/\/doi.org\/10.1097\/NEN.0b013e3181a3240b","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"9920_CR28","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","volume":"37","author":"PMK de Blank","year":"2017","unstructured":"de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, Avery RA (2017) Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J Neuroophthalmol 37(Suppl 1):S23\u2013S32. https:\/\/doi.org\/10.1097\/WNO.0000000000000550","journal-title":"J Neuroophthalmol"},{"key":"9920_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajmg.a.20211","volume":"122A","author":"A King","year":"2003","unstructured":"King A, Listernick R, Charrow J, Piersall L, Gutmann DH (2003) Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A 122A:95\u201399. https:\/\/doi.org\/10.1002\/ajmg.a.20211","journal-title":"Am J Med Genet A"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09920-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-023-09920-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09920-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T05:11:12Z","timestamp":1680844272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-023-09920-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["9920"],"URL":"https:\/\/doi.org\/10.1007\/s10633-023-09920-3","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"type":"print","value":"0012-4486"},{"type":"electronic","value":"1573-2622"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Republic of Slovenia National Medical Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study\u00a0(retrospective review), formal consent is not required; however, informed content was obtained from all individual participants for whom identifying information is included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All applicable international, national, and\/or institutional guidelines for the treatment of human participants were followed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"No animals were used in this research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}